🇺🇸 FDA
Patent

US 10130604

Composition and method for treating neurodegenerative disease

granted A61KA61K31/19A61K31/192

Quick answer

US patent 10130604 (Composition and method for treating neurodegenerative disease) held by The Regents of the University of Colorado, a Body Corporate expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/19, A61K31/192, A61K31/21, A61K31/216